Find Legal Topics > Drugs Laws > Aricept Patch

Aricept Patch


What is Aricept Used for?

When asking what Aricept is used for, one must understand that it is a prescription drug, used only for the treatment of Alzheimer’s disease and its derivatives. Aricept is the brand name of donepezil—a cholinesterase inhibitor that prevents the breakdown of acetylcholine, which is a chemical that is vital for thinking, memory and reasoning. Therefore, when thinking about what is Aricept used for, understand that is prescribed to patients suffering from Alzheimer’s disease or common conditions such as Dementia. 

What is Aricept Used for?

Aricept, in the United States, is the number one prescribed drug to impede the ill-effects of Alzheimer’s disease. The United States Food and Drug Administration approved Aricept in 1996 for mild to moderate form of the disease—the drug was later approved to treat sever AD in 2006. So, when wondering what Aricept is used for, remember that the pill is connected to the treatment of Alzheimer’s disease. 

When wondering what Aricept is used for, you must understand how the pill works. Aricept, to answer what is Aricept used for, improves the function of nerve cells by reducing the destruction of acetylcholine. 

Aricept, to understand what is Aricept used for, sends messages to the nerve cells involved with several cognitive skills, including thinking, memory and reasoning. By reducing the destruction of the acetylcholine enzyme, the progression of the Alzheimer’s disease slows down. It must be stated: when asking what is Aricept used for, understand that it is used to improve cognitive functions only for patients who suffer from Alzheimer’s disease; however, the effects of the drug will vary based on case by case circumstances.

What is the Aricept Patch?

The Aricept patch is a relatively new method of delivering donepezil to patients with Alzheimer’s disease. The United States Food and Drug Administration approved the review of the Aricept patch in September of 2010. 

The Erisia Aricept patch was intended to release donepezil in AD patients via a Nicorette-like arm patch. The Erisia Aricept patch was supposed to replace the pill-form of the drug; however, US regulators, in April of 2011, rejected the Aricept patch. The Japanese maker responsible for creating the Aricept patch claimed that the Aricept patch was rejected because of a lack of understanding regarding the medicine’s effectiveness. In response, the United States Food and Drug Administration cited the Aricept patch’s dangers as the reason for rejection—regulators cited unknown side effects of the Aricept patch as the reason for its rejection. Because of its rejection, you will not be able to purchase or be prescribed the Aricept patch in the United States. Only the pill form of the drug may be attained to treat Alzheimer’s disease. 

Related Topics